MedPath

Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee

Phase 3
Completed
Conditions
Osteoarthritis of the Knee
Interventions
Registration Number
NCT00722852
Lead Sponsor
IDEA AG
Brief Summary

The purpose of this study is to provide replicated evidence of safety and efficacy of 100 mg ketoprofen in Diractin®.

Detailed Description

The study will investigate safety and efficacy of Diractin® at relieving signs and symptoms of knee OA, including the primary endpoint of patient assessment of pain.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
555
Inclusion Criteria
  • Informed consent signed and dated
  • Age > 45 years
  • Class I-III OA of the knee and subject meets American College of Rheumatology (ACR) clinical classification criteria for osteoarthritis of the knee
Exclusion Criteria
  • Skin lesions or dermatological diseases in the treatment area
  • Directly or indirectly involved in the conduct and administration of this study
  • Received any investigational medicinal product within 30 days prior to Screening Visit or participation in any previous clinical study with Diractin®
  • Pregnancy or lactation
  • Residents of psychiatric wards, prisons or other state institutions
  • Malignancy within the past 2 years
  • Depressive disorders requiring treatment with tricyclics, treatment with other antidepressants must be stable for 3 months prior to screening and throughout the study
  • Epilepsy
  • Schizophrenia
  • Neuropathic pain and any other pain condition requiring chronic use of pain medication
  • Known hypersensitivity or allergy (including photoallergy) to NSAID´s including ketoprofen and to ingredients of the IMP
  • Preexisting asthma or bronchospasm after taking aspirin or other NSAIDs
  • Unable to discontinue analgesic therapy including opioids, NSAID´s, tramadol, muscle relaxants, gabapentin, pregabalin, duloxetine, venlafaxine, capsaicine or other drugs approved or used for the treatment of pain for the duration of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1ketoprofen in Diractin®-
2Placebo-
Primary Outcome Measures
NameTimeMethod
pain subscale of the WOMACweek 12
Secondary Outcome Measures
NameTimeMethod
Patient global assessment of response to therapyweek 12
function subscale of the WOMACweek 12

Trial Locations

Locations (37)

Family Practice Lynn Institute of the Ozarks

🇺🇸

Little Rock, Arkansas, United States

Premiere Pharmaceutical Research

🇺🇸

Tempe, Arizona, United States

Pharcotherapy Research Associate, Inc.

🇺🇸

Zanesville, Ohio, United States

Tampa Bay Medical Research Inc.

🇺🇸

Clearwater, Florida, United States

Genova Clinical Research

🇺🇸

Tucson, Arizona, United States

Hope Research Institute

🇺🇸

Phoenix, Arizona, United States

Quality Research Inc.

🇺🇸

San Antonio, Texas, United States

Progressive Clinical Research

🇺🇸

San Antonio, Texas, United States

FPA Clinical Research

🇺🇸

Kissimmee, Florida, United States

Orange County Clinical Trails, Inc.

🇺🇸

Anaheim, California, United States

Encompass Clinical Research

🇺🇸

Spring Valley,, California, United States

DSI

🇺🇸

Jupiter, Florida, United States

University Clinical Research DeLand, LCC

🇺🇸

Deland, Florida, United States

Eastern Research

🇺🇸

Hialeah, Florida, United States

Suncoast Clinical Research Family Practice

🇺🇸

New Port Richey,, Florida, United States

Renstar Medical Research

🇺🇸

Ocala, Florida, United States

University Clinical Research, Inc.

🇺🇸

Pembroke Pines, Florida, United States

Clinical Research Atlanta

🇺🇸

Stockbridge,, Georgia, United States

Miami Research Associates

🇺🇸

South Miami, Florida, United States

Drug Studies America

🇺🇸

Marietta, Georgia, United States

Future Care Studies

🇺🇸

Springfield, Massachusetts, United States

Non-Surgical Orthopaedic & Spine Center, P.C.

🇺🇸

Marietta,, Georgia, United States

Advance Clinical Research Insititute

🇺🇸

Boise, Idaho, United States

Westside Family Medical Center, P.C.

🇺🇸

Kalamazoo, Michigan, United States

Lousianna Research Associates Inc. (LRC, Inc)

🇺🇸

New Orleans,, Louisiana, United States

Omaha Research, P.C.

🇺🇸

Omaha, Nebraska, United States

Rochester Clinical Research

🇺🇸

Rochester, New York, United States

Wake Research Associates, LLC

🇺🇸

Raleigh, North Carolina, United States

Altoona Center for Clinical Research

🇺🇸

Duncansville, Pennsylvania, United States

Founders Research Group Research

🇺🇸

Philadelphia, Pennsylvania, United States

Rapid Medical Research, Inc.

🇺🇸

Cleveland, Ohio, United States

Coastal Carolina Research Center

🇺🇸

Goose Creek,, South Carolina, United States

Omega Medical Research

🇺🇸

Warwick, Rhode Island, United States

Sarah Cannon Research Institute

🇺🇸

Jackson, Tennessee, United States

The Center of Clinical Research LLC

🇺🇸

Winston-Salem, North Carolina, United States

MediSphere Medical Research Center, LLC

🇺🇸

Evansville, Indiana, United States

Integrated Clinical Trail Services, Inc.

🇺🇸

West Des Moines, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath